Therapie mit Dexamethason bei Patienten mit COVID-19

Research output: Contribution to journal › Research article › Contributed

Contributors

  • M Kolditz - , Department of internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • D Dellweg - , Specialist Hospital Kloster Grafschaft GmbH (Author)
  • H Geerdes-Fenge - , Rostock University Medical Centre (Author)
  • P M Lepper - , University Hospital of Saarland (Author)
  • T Schaberg - , Agaplesion Diakonieklinikum Rotenburg (Author)
  • S Ewig - , Thoraxzentrum Ruhrgebiet (Author)
  • M Pfeifer - , University Hospital Regensburg, Fachklinik für Lungenerkrankungen Donaustauf, Barmherzige Brüder Hospital Regensburg (Author)
  • T Bauer - , Helios Hospital Emil von Behring (Author)
Translated title of the contribution
Treatment with Dexamethasone in Patients with COVID-19 - A Position Paper of the German Respiratory Society (DGP)

Details

Original languageGerman
Pages (from-to)493-495
Number of pages3
JournalPneumologie
Volume74
Issue number8
Publication statusPublished - Aug 2020
Peer-reviewedNo

External IDs

PubMedCentral PMC7516361
ORCID /0000-0001-6022-6827/work/127321410
Scopus 85088848523

Keywords

Keywords

  • Anti-Inflammatory Agents/therapeutic use, Betacoronavirus, COVID-19, Coronavirus/isolation & purification, Coronavirus Infections/diagnosis, Dexamethasone/therapeutic use, Germany, Humans, Pandemics, Pneumonia, Viral/diagnosis, Practice Guidelines as Topic, SARS-CoV-2, Societies, Medical, Treatment Outcome, COVID-19 Drug Treatment